| CHARLIE
Chemical Template |
|
|
| Target Bond Tolerance |
|
| 0.75 Angs RMSD overlap |
|
|
|
| Site Level
Requirements |
|
| Total
# rotatable bonds = 4 |
|
|
|
|
| Defined Component #1 |
||
| Atypes: O.3
& O.2 > 0 |
||
| Require 6-10 ring atoms |
||
|
|
|
| Pharmacophore requirements |
||
| Hbond acceptor atom within |
||
| 1.0
angs of specified {xyz} |
||
| © 2003 Drug
Design Methodologies, L.L.C. |